Press-release for stocks

crawled date : 2022 - 01 - 18 source : Www.biospace.com

save search

23andMe Announces Extension of GSK Collaboration and Update on Joint Immuno-oncology Program
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
GLAXF | News | $19.54 -14.18% 2.6K

Health Technology

| -14.67% | O: -3.8% H: 6.54% C: 6.21%
GSK | News | $40.86 -0.92% -0.15% 1.7M

Health Technology

| -8.94% | O: 2.34% H: 0.0% C: 0.0%
collaboration

Immuneering Strengthens Board of Directors with the Appointment of Diana F. Hausman, M.D.Industry Executive Brings More than 20 Years of Clinical Drug Development Expertise
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
IMRX | $1.5 -7.98% -8.67% 470K

| -87.46% | O: 0.85% H: 3.81% C: -5.42%
ZYME | $8.555 -0.06% -0.06% 590K

Health Technology

| -42.82% | O: -0.87% H: 1.21% C: -9.77%
BPMC | $92.31 0.02% 0.02% 560K

Health Technology

| 18.32% | O: -1.6% H: 0.99% C: -4.69%
AMGN | News | $273.085 -0.17% -0.17% 2.5M

Health Technology

| 18.49% | O: 1.4% H: 0.0% C: 0.0%
drug

Gilead Sciences to Release Fourth Quarter & Full Year 2021 Financial Results on Tuesday, February 1, 2022
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M

Health Technology

| -6.79% | O: -0.65% H: 0.0% C: 0.0%
financial results ces results

Vertex to Announce Fourth Quarter 2021 Financial Results on January 26
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
VRTX | $400.66 -1.05% -1.06% 810K

Health Technology

| 72.99% | O: -1.12% H: 0.46% C: -0.16%
financial results results

Doximity to Release Fiscal 2022 Third Quarter Results on February 8, 2022
Published: 2022-01-18 (Crawled : 23:00) - biospace.com/
DOCS | $23.91 -2.73% 0.38% 1.8M

Professional, Scientific, and T...

| -46.6% | O: -0.54% H: 1.09% C: -6.44%
results

Krystal Biotech Appoints Jing Marantz, MD, PhD, MBA as Chief Business Officer and Rand Sutherland, MD, MPH to its Board of Directors
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -8.64% | O: 1.98% H: 0.0% C: 0.0%
KRYS | News | $159.05 -1.85% -1.88% 240K

Health Technology

| 160.18% | O: -0.31% H: 0.21% C: -4.33%
ARCT 4 | $27.0 -3.33% -3.44% 270K

Health Technology

| -16.58% | O: -3.43% H: 0.0% C: -15.84%
biotech iot

Novo Integrated Sciences Reports First Quarter Financial Results
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
NVOS | $0.5265 2.23% 2.18% 480K

Manufacturing

| -60.6% | O: -1.51% H: 5.38% C: 5.38%
financial results ces report results

Rocket Lab Closes Acquisition of Space Solar Power Products Company SolAero Holdings, Inc.
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
RKLB | $3.685 0.14% 0.14% 6.1M

| -64.68% | O: -1.49% H: 3.02% C: -1.7%
solar acquisition space spac

Global Coalition for Adaptive Research Announces Key Updates on GBM AGILE Phase 2-3 Adaptive Platform Trial for Patients With Glioblastoma
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
BHVN | News | $38.72 -2.25% -0.28% 970K

Health Technology

| -67.58% | O: -1.78% H: 0.59% C: -1.67%
phase 2 research trial platform glioblastoma

Chimerix Announces Publication of Positive ONC201 Data from Phase 2 Study in Neuroendocrine Tumors in Clinical Cancer Research
Published: 2022-01-18 (Crawled : 22:00) - biospace.com/
CMRX | $0.9033 -2.38% -2.44% 88K

Health Technology

| -84.5% | O: -1.33% H: 1.52% C: -5.07%
onc201 phase 2 research positive endocrine cancer

Gilead Alleges $250 Million of Counterfeit HIV Drugs Were Sold Over 2 Years
Published: 2022-01-18 (Crawled : 21:00) - biospace.com/
JNJ | News | $148.53 -0.69% -0.14% 9.6M

Health Technology

| -11.24% | O: -0.88% H: 0.0% C: 0.0%
drug hiv

Chamath Palihapitiya-Supported SPAC Backs ProKidney in $2.64B Deal
Published: 2022-01-18 (Crawled : 20:00) - biospace.com/
RPRX | $27.98 0.58% 0.57% 1.8M

Health Technology

| -30.09% | O: -0.01% H: 2.15% C: 1.33%
deal spac

Mahana Therapeutics Selected for Prestigious Digitalhealth.London Accelerator Program
Published: 2022-01-18 (Crawled : 19:00) - biospace.com/
PPRUF | News | $340.0 37.56% 1.5K

Consumer Non-Durables

| -56.44% | O: -2.63% H: 1.5% C: 0.9%
PPRUY | News | $33.79 -0.11% 360K

Manufacturing

| -55.84% | O: -0.22% H: 0.93% C: -0.64%
health therapeutics cel accelerator program program

Compugen Expands COM701 Intellectual Property Portfolio with New U.S. Patent Covering Triple Combination Use with anti-PD-1 and anti-TIGIT Antibodies
Published: 2022-01-18 (Crawled : 16:00) - biospace.com/
CGEN | $2.03 3.57% 3.45% 450K

Health Technology

| -41.13% | O: -2.57% H: 3.43% C: 0.26%
com701 patent intel antibody

Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery
Published: 2022-01-18 (Crawled : 16:00) - biospace.com/
SRGA | $0.1829 -50.36% 8.7M

Health Technology

| -67.74% | O: 20.57% H: 5.88% C: -21.35%
fda clearance system fda clearance spine

Aktis Oncology Expands Leadership Team with Two Strategic Hires
Published: 2022-01-18 (Crawled : 16:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M

Health Technology

| 195.29% | O: -3.01% H: 2.38% C: 1.78%